Sodium phosphate (NaHPO4)

Weekly News Recap
#Phispers

Stock Recap
#PipelineProspector

Virtual Booth

Contact Supplier

Access all COS suppliers
Check all USDMF suppliers

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

22 API Suppliers, 9 USDMF, 1 CEP/COS, 1 EU WC, 5 NDC API, 10 Listed Suppliers

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

FINISHED DOSAGE FORMULATIONS

56 FDF Dossiers, 18 FDA Orange Book, 8 Europe, 11 Canada, 18 South Africa, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;IRRIGATION - 0.154MG/ML;0.92MG/ML;0.184MG/ML;0.2MG/ML;0.38MG/ML;2.1MG/ML;7.14MG/ML;0.42MG/ML, INJECTABLE;INJECTION - 3.68GM/1000ML;3.05GM/1000ML;0.314GM/1000ML ;3.09GM/1000ML;6.34GM/1000ML;0.187GM/1000ML (5000ML), INJECTABLE;INJECTION - N/A/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;6.95GM/1000ML;0.187GM/1000ML (5000ML)

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 5 Rochem International Inc, 19 SPI Pharma, 6 DKSH, 3 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 8 Kirsch Pharma, 1 ACG Worldwide, 17 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 17 BASF, 1 CD Formulation, 2 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 2 Finar, 11 Gangwal Chemicals, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 22 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 34 Roquette, 15 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

76 Fillers, Diluents & Binders, 49 Coating Systems & Additives, 33 Direct Compression, 33 Thickeners and Stabilizers, 33 Parenteral, 31 Disintegrants & Superdisintegrants, 28 Solubilizers, 27 Taste Masking, 25 Granulation, 23 Controlled & Modified Release, 21 Topical, 20 Chewable & Orodispersible Aids, 19 Film Formers & Plasticizers, 18 Lubricants & Glidants, 15 Co-Processed Excipients, 11 Emulsifying Agents, 8 Surfactant & Foaming Agents, 8 API Stability Enhancers, 7 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 5 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 8 Regulatory FDF Prices

MARKET PLACE

17 APIs, 13 EXCIPIENTS, 1 Intermediates

PATENTS & EXCLUSIVITIES

1 US Patents

1 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM

2 EDQM

Xls

Filters

Company Name

Year

DEALS // DEV.

Country

Sponsor

Therapeutic Area

Study Phase

Deal Type

Product Type

Dosage Form

Lead Product

Target

Filters

Reset Filter

All Developments

Therapeutic Area by Lead Product

Study Phase by Lead Product

Company by Lead Product

Top Deals by Deal Size (USD bn)

Reset All

01

American Regent

U.S.A

CPhI Korea

Not Confirmed

Not Confirmed

Find Clinical Drug Pipeline Developments & Deals for Sodium phosphate (NaHPO4)